Related Experiment Video
Updated: Sep 13, 2025

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Stoichiometric 14-3-3ζ binding promotes phospho-Tau microtubule dissociation and reduces aggregation and condensation
Janine Hochmair1, Maxime C M van den Oetelaar2, Leandre Ravatt1,3,4
1German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Abstract:
The microtubule (MT) association of protein Tau is decreased upon phosphorylation. Increased levels of phosphorylated Tau in the cytosol pose the risk of pathological aggregation, as observed in neurodegenerative diseases. We show that binding of 14-3-3ζ enhances cytosolic Tau solubility by promoting phosphorylated Tau removal from MTs, while simultaneously inhibiting Tau aggregation both directly and indirectly via suppression of condensate formation. These 14-3-3ζ activities depend on site-specific binding of 14-3-3 to Tau phosphorylated at S214 and S324. At sub-stoichiometric 14-3-3ζ concentrations, or in the presence of other 14-3-3ζ binding partners, multivalent electrostatic interactions promote Tau:14-3-3ζ co-condensation, offering a phosphorylation-independent mode of Tau-14-3-3ζ interactions. Given the high abundance of 14-3-3 proteins in the brain, 14-3-3 binding could provide efficient multi-modal chaperoning activity for Tau in the healthy brain and be important for preventing Tau aggregation in disease.
Insights
14-3-3ζ protein binding enhances Tau solubility and prevents its aggregation by detaching phosphorylated Tau from microtubules. This protein acts as a chaperone, crucial for brain health and preventing neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Microtubule (MT) association of Tau protein decreases with phosphorylation.
- Increased cytosolic phosphorylated Tau risks pathological aggregation, linked to neurodegenerative diseases.
Purpose of the Study:
- To investigate the role of 14-3-3ζ in regulating Tau solubility and aggregation.
- To elucidate the mechanisms by which 14-3-3ζ interacts with Tau.
Main Methods:
- Investigated Tau-microtubule interactions and Tau aggregation.
- Analyzed the effect of 14-3-3ζ binding on phosphorylated Tau.
- Studied Tau:14-3-3ζ co-condensation dynamics.
Main Results:
- 14-3-3ζ binding enhances cytosolic Tau solubility by promoting phosphorylated Tau removal from MTs.
- 14-3-3ζ inhibits Tau aggregation directly and indirectly by suppressing condensate formation.
- Site-specific binding to phosphorylated Tau (S214, S324) mediates these effects.
- Multivalent electrostatic interactions enable phosphorylation-independent Tau:14-3-3ζ co-condensation.
Conclusions:
- 14-3-3ζ acts as a multi-modal chaperone for Tau in the healthy brain.
- 14-3-3ζ binding is critical for preventing Tau aggregation and mitigating neurodegenerative disease risk.
Related Concept Videos
Drugs that Stabilize Microtubules
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Microtubule Instability
Microtubule Associated Proteins (MAPs)

